The FIGHT-RP1 Study

NCT03063021 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Retinitis Pigmentosa

Interventions

DRUG: N-Acetyl Cysteine (NAC)

Sponsor

Johns Hopkins University